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The Yeast Phosphatidylinositol Kinase
Homolog TOR2 Activates RHO1 and RHO2
via the Exchange Factor ROM2
Anja Schmidt, Marc Bickle, Thomas Beck, second essential function of TOR2 is unique to TOR2.
We have shown recently that loss of the TOR2-uniqueand Michael N. Hall
function disrupts the cell cycle–dependent polarizedDepartment of Biochemistry
distribution of the actin cytoskeleton (Schmidt et al.,Biozentrum
1996). Overexpression of CCT6/TCP20, encoding a sub-University of Basel
unit of the TCP-1 chaperonin that is involved in theCH-4056 Basel
folding and assembly of actin structures, suppresses theSwitzerland
lethality of a tor2 mutation and partly restores polarized
distribution of the actin cytoskeleton. These results sug-
gested that the unique function of TOR2 is required forSummary
organization of the actin cytoskeleton. However, it is not
known how TOR2 might signal to the actin cytoskeleton.The Saccharomyces cerevisiae phosphatidylinositol
In the budding yeast Saccharomyces cerevisiae, thekinase homolog TOR2 is required for organization of
cell cycle–dependent asymmetric distribution of the ac-the actin cytoskeleton. Overexpression of RHO1 or
tin cytoskeleton is essential for establishing and main-RHO2, encoding Rho-like GTPases, or ROM2, encod-
taining cell polarity and for targeting secretion to theing a GDP/GTP exchange factor for RHO1 and RHO2,
growing bud (Adams and Pringle, 1984; Kilmartin andsuppresses a tor2 mutation. Deletion of SAC7, a gene
Adams, 1984; Drubin, 1991). Like in mammalian cells,originally identified as a suppressor of an actin muta-
the organization of the actin cytoskeleton in yeast cellstion, also suppresses a tor2 mutation. SAC7 is a novel
is controlled by Rho-like GTPases (Hall, 1994; MacheskyGTPase-activating protein for RHO1. ROM2 exchange
and Hall, 1996; Ridley, 1996). Several Rho-like GTPases,activity is reduced in a tor2 mutant, and overexpres-
including CDC42, RHO1, RHO2, RHO3, and RHO4, havesion of ROM2 lacking its PH domain can no longer
been identified in yeast (Madaule et al., 1987; Adams etsuppress a tor2 mutation. Thus, TOR2 signals to the
al., 1990; Johnson and Pringle, 1990; Ziman et al., 1991;actin cytoskeleton through a GTPase switch com-
Matsui and Toh-e, 1992), and most, if not all, controlposed of RHO1, RHO2, ROM2, and SAC7. TOR2 acti-
organization of the actin cytoskeleton and polarized cellvates this switch via ROM2, possibly via the ROM2 PH
growth. Cells lacking CDC42 are defective in the polar-domain.
ization of the actin cytoskeleton and arrest as large
unbudded cells because of a failure in bud emergence
Introduction (Adams et al., 1990; Johnson and Pringle, 1990; Ziman
et al.,1991). Cells lacking RHO3 and RHO4 diewith small
The Saccharomyces cerevisiae TOR1 and TOR2 pro- buds, lyse, and also have a random actin distribution
teins were originally identified as the targets of the (Matsui and Toh-e, 1992b; Imai et al., 1996). RHO1 and
immunophilin–immunosuppressantcomplexFKBP–rap- possibly its nonessential homolog RHO2 have been im-
amycin (Heitman et al., 1991; Cafferkey et al., 1993; Kunz plicated in cell wall synthesis and organization of the
et al., 1993; Helliwell et al., 1994). They are the founding actin cytoskeleton and may thus control both cell shape
members of a novel family of structurally homologous and polarity. Cells lacking RHO1 stop growing as small-
signaling proteins implicated in cell cycle control (Keith budded cells and lyse, and RHO1 is located along with
and Schreiber, 1995; Zakian, 1995). This family also in- cortical actin patches at the presumptive budding site,
cludes the yeast MEC1, TEL1, and RAD3; the Drosophila the bud tip, and the site of cytokinesis (Yamochi et al.,
MEI-41; and the mammalian FRAP/RAFT/mTOR, ATM, 1994). Cells lacking RHO2 have no evident phenotype,
FRP1, and DNA-PK proteins. Each of these proteins but overexpression of RHO2 can suppress a dominant
contains a lipid kinase motif near its carboxyl terminus negative RHO1 mutation (Ozaki et al., 1996). RHO1 con-
and is thus related to phosphatidylinositol (PI) 3- and PI trols cell wall synthesis, as suggested by the lysis phe-
4-kinases. The demonstration that DNA-PK, the most notype of a rho1 mutant, in two different ways. First,
distant member of the family, is an authentic protein RHO1 is a regulatory subunit of b(1→3) glucan synthase
kinase has led some to suggest that the TOR family (Drgonova et al., 1996; Qadota et al., 1996). Glucan poly-
members in general are protein kinases (Hartley et al., mers are the major structural component of the yeast
1995; Hunter, 1995); however, it remains to be deter- cell wall. Second, GTP-RHO1 binds and activates PKC1,
mined whether they are indeed lipid and/or protein ki- which in turn controls glucan synthases via a MAP
nases. kinase cascade (Levin and Bartlett-Heubusch, 1992;
The putative PI kinase TOR2 has two essential func- Errede and Levin, 1993; Roemer et al., 1994; Nonaka et
tions (Kunz et al., 1993; Helliwell et al., 1994; Zheng et al., 1995; Igual et al., 1996; Kamada et al., 1996). RHO1
al., 1995; Hall, 1996). One function is redundant with might also control the actin cytoskeleton. It colocalizes
TOR1 and is required for signaling activation of transla- with actin patches, and human RhoA, which is highly
tion initiation and, thereby, early G1 progression in re- homologous to RHO1 and mediates actin reorganization
sponse to nutrient availability (Barbet et al., 1996; Di in mammalian cells, can substitute for RHO1 in yeast
Como and Arndt, 1996). This signaling pathway, like (Qadota et al., 1994). Furthermore, mutants lacking the
TOR itself, appears to be conserved in mammalian cells PKC1-controlled MAP kinase MPK1/SLT2 have a delo-
calized actin cytoskeleton (Mazzoni et al., 1993).(Beretta et al., 1996; von Manteuffel et al., 1996). The
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Several regulators of RHO1 and RHO2 have been iden-
tified. BEM2 is a GTPase-activating protein (GAP) for
RHO1 (Peterson et al., 1994) and probably also for
RHO2. RDI1 is a GDP dissociation inhibitor for RHO1
(Masuda et al., 1994). ROM1 and ROM2 contain a GDP/
GTP exchange domain and a pleckstrin homology (PH)
domain, and at least ROM2 is a GDP/GTP exchange
factor (GEF) for RHO1. Both ROM1 and ROM2 are
multicopy suppressors of a dominant negative RHO1
allele (Ozaki et al., 1996). However, the mechanism by
which RHO1, RHO2, and their regulators (and ultimately
cell shape and polarity) are controlled is not known.
Here, we show that TOR2 activates RHO1 and RHO2
via their exchange factor ROM2. Overexpression of
RHO1, RHO2, or ROM2 suppresses the lethality of a tor2
mutation, and ROM2 GEF activity is severely reduced in
a tor2 mutant. Overexpression of a mutant ROM2 protein
lacking its PH domain cannot suppress a tor2 mutation, Figure 1. Deletion of SAC7 Suppresses the Growth Defect of a tor2ts
Mutant but Not of a tor1 tor2ts Double Mutantraising the possibility that the PI kinase homolog TOR2
Wild-type TOR2 (JK9-3da), tor2ts (SH121), sac7 tor2ts (AS103-2a),signals to ROM2 via the ROM2 PH domain. In addition,
tor1 tor2ts (SH221), and sac7 tor1 tor2ts (AS114-4c) cells werewe show that SAC7, a gene originally identified as a
streaked out on YPD and incubated at 308C or 378C. tor2ts and tor1genomic suppressor of actin mutations (Dunn and
tor2ts cells are not viable at 378C.
Shortle, 1990), encodes a novel GTPase-activating pro-
tein for RHO1. Loss of SAC7 restores growth in cells
lacking TOR2, indicating that SAC7 antagonizes theacti-
similar to what has been described previously (Dunn andvation of RHO1 by ROM2 and TOR2. Thus, TOR2 is an
Shortle, 1990). The sac7 strain AS100-6a was crossed toupstream component in a signaling pathway controlling
tor2ts strain AS100-3c to generate diploid AS103, andpolarized cell growth and possibly cell shape.
the segregants from 18 tetrads derived from AS103 were
examined for growth on rich medium at the nonpermis-
sive temperature (378C) for the tor2ts mutation. WhileResults
tor2ts segregants were not viable at this temperature,
sac7 tor2ts double mutants grew almost like TOR2 wild-Disruption of SAC7 Restores Growth
type cells (Figure 1). The SAC7 deletion also suppressedin a tor2 Mutant
a tor2 null allele (data not shown); sac7 tor2ts segregantsPrevious results indicated that TOR2 is required for or-
cleared of theplasmid-borne tor2ts allele werestill viable.ganization of the actin cytoskeleton (Schmidt et al.,
We next tested whether loss of SAC7 could also restore1996). The first indication of the nature of this require-
growth in a tor1 tor2ts double mutant. The sac7 strainment came from our isolation of SAC7, as follows. In
AS109-19c was crossed to tor1 tor2ts strain SH221. Thestudies to be described elsewhere (M. B. and M. N. H,
resulting diploid strain (AS114) was sporulated and dis-unpublished data), we have identified recessive muta-
sected at 308C, and segregants from 30 tetrads weretions ineither one of two genes, termed ROT1 and ROT2,
examined for growth at 378C. As shown in Figure 1, sac7that suppress the growth defect of a tor2 mutant. SAC7
tor1 tor2ts cells were not viable at 378C. Growth curveswas isolated as a dosage suppressor of the synthetic
and FACS analysis showed that after shift to the nonper-lethality conferred by the combination of our suppressor
missive temperature, sac7 tor1 tor2ts cells died withinmutations in ROT1 and ROT2. SAC7 (suppressor of
one generation as large unbudded cells with a 1n DNAactin) was originally identified as an extragenic suppres-
content, as do tor1 tor2ts cells (data not shown). Thesesor of the temperature-sensitive growth defect con-
results show that disruption of SAC7 suppresses theferred by the actin mutation act1-4 (Dunn and Shortle,
loss of the TOR2-unique function but not the loss of1990). Null alleles of SAC7 restore growth in act1-1 and
the TOR1-shared function and suggest that SAC7 isact1-4 mutants that are defective in the polarized distri-
involved in the TOR2-mediated control of the actin cy-bution of the actin cytoskeleton. At low temperatures,
toskeleton. The finding that a SAC7 deletion suppressesstrains disrupted in SAC7 are not viable and display
a tor2 null allele suggests that SAC7 is downstream ofaberrant actin assembly. These findings led Dunn and
TOR2.Shortle to suggest that SAC7 is involved in the assembly
and function of actin and might have actin-severing ac-
tivity. SAC7 Encodes a Novel Rho-Type
GTPase-Activating ProteinWe asked if a SAC7 disruption, like rot1 and rot2
mutations, could also restore growth in a tor2 mutant The resequencing of the SAC7 gene by the yeast ge-
nome sequencing project revealed that SAC7 is largerthat is defective in the polarized distribution of the actin
cytoskeleton. The SAC7 gene was deleted in our wild- than previously published (Dunn and Shortle, 1990). The
new SAC7 open reading frame contains 1965 nucleo-type strain JK9-3da (see Experimental Procedures). The
obtained sac7 strains grew normally at 308C and 378C tides, extended by 763 bp at the 59 end and by 400 bp
at the 39 end, and predicts a protein of 654 amino acidsand were very severely impaired for growth at 158C,
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Figure 2. SAC7 Encodes a Novel Rho-Type
GTPase-Activating Protein
An alignment of the Rho-GAP domains of the
six known or predicted yeast Rho-type GAPs,
SAC7, BAG7, BEM2, BEM3, RGA1, and LRG1
(Mu¨ller et al., 1994), human breakpointcluster
regions (Bcr) protein (Heisterkamp et al.,
1985), human n-chimaerin (Hall et al., 1990),
and p50rhoGAP (Barfod et al., 1993; Lancas-
ter et al., 1994) is presented. Conserved resi-
dues are indicated by shading. The highly
conserved subdomains are boxed.
with a molecular mass of 73.6 kDa. A homology search the high copy number plasmids pBEM2, pBEM3,
pRGA1, or pBAG7 (and pSAC7 and an empty vectorof the current EMBL and GenBank data bases with the
extended SAC7 open reading frame identified a domain as controls) and examined for growth at 378C. While
providing SAC7 prevented growth in sac7 tor2ts cellsin SAC7 (aa residues 151–370) that showed significant
similarity to sequences common to Rho-type GTPase- at 378C, sac7 tor2ts cells containing pBEM3, pRGA1,
pBAG7, or the empty vector grew like the parental sac7activating proteins. An alignment of the GAP domain of
SAC7 and that of other known Rho-GAPs from yeast tor2ts strain (data not shown). The sac7 tor2ts cells con-
taining pBEM2 gave an intermediate result of poorand mammalian cells is shown in Figure 2. Evidence
presented below indicates that SAC7 is indeed a Rho- growth. Third, we determined whether overexpression
of BEM2, BEM3, RGA1, or BAG7 could suppress thetype GAP. A search of the entire sequence of the yeast
genome also identified a thus far uncharacterized yeast growth defect of a sac7 mutant at 158C. The sac7 strain
MB75-1c was transformed with the high copy numberopen reading frame (YOR134W) as encoding the closest
SAC7 homolog. This structural homolog was termed plasmids pBEM2, pBEM3, pRGA1, or pBAG7 (and
pSAC7 and an empty vector as controls) and examinedBAG7. BAG7 is a protein of 409 aa with a predicted
molecular mass of 46.2 kDa. BAG7 shows 42% overall for growth at 158C. Overexpression of BEM2, BEM3, or
RGA1 did not suppress the growth defect of cells lackingidentity to SAC7 and also contains a Rho-GAP domain
that is 57% identical to the GAP domain of SAC7 SAC7. However, overexpression of BAG7 completely
suppressed the cold sensitivity of a sac7 strain. Thus,(Figure 2).
The homology between SAC7 and Rho-GAPs led us BAG7 has at least partly overlapping function with SAC7
but neither BAG7, BEM3, nor RGA1 appeared to beto examine whether any of the other actin-related yeast
Rho-GAPs (BEM2, BEM3, and RGA1) or BAG7 is also involved in the function of TOR2. BEM2 may be involved
in TOR2 function, as suggested by the poor growth ofinvolved in TOR2 function (Zheng et al., 1993; Zheng et
al., 1994; Stevenson et al., 1995; Chen et al., 1996). sac7 tor2ts cells containing pBEM2, although a BEM2
disruption was not able to suppress a tor2ts mutation.First, we determined whether a deletion of BEM2, BEM3,
RGA1, or BAG7 could suppress the lethality caused
by a tor2ts mutation as does a SAC7 deletion. Strains Overexpression of RHO2 or RHO1
Suppresses a tor2 Mutationindividually disrupted for BEM2, BEM3, RGA1, and
BAG7 were constructed (see Experimental Procedures) Since SAC7 has homology to Rho-type GTPase-activat-
ing proteins, we examined whether any of the knownand crossed to a tor2ts mutant. Diploids (AS149, AS124,
AS131, and AS130) were dissected and tor2ts segregants Rho-like GTPases in yeast are involved in TOR2 func-
tion. High copy number plasmids encoding the Rho-containing a GAP gene disruption were tested for growth
at 378C. Unlike disruption of SAC7, disruption of BEM2, like GTPases (pCDC42, pRHO1, pRHO2, pRHO3, and
pRHO4) or an empty vector were transformed into tor2tsBEM3, RGA1, or BAG7 did not restore growth in a tor2ts
mutant at the nonpermissive temperature (data not strain SH121, and growth of transformants was moni-
tored at 378C. Whereas tor2ts cells transformed withshown). Second, we determined whether overexpres-
sion of BEM2, BEM3, RGA1, or BAG7 could suppress pCDC42, pRHO1, pRHO3, pRHO4, or an empty vector
were inviable at 378C, tor2ts cells transformed withthe growth of a sac7 tor2ts strain at 378C. The sac7 tor2ts
strains AS103-2a and AS147-1a were transformed with pRHO2 grew at 378C, almost like wild-type cells (Figure
Cell
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Figure 3. Overexpression of RHO2 or RHO1 Suppresses a tor2 Mutation
(A) Wild-type TOR2 (JK9-3da) cells; tor2ts (SH121) cells carrying an empty vector or pCDC42, pRHO1, pRHO2, pRHO3, pRHO3* (containing
RHO3val25), or pRHO4; and tor2ts (AS129-1d) cells carrying pCDC42* (containing CDC42val12) were streaked out on YPD and incubated at 308C
or 378C. tor2ts cells (SH121, AS129-1d) carrying an empty vector are not viable at 378C.
(B) Wild-type TOR2 (JK9-3da) and tor2ts (SH137) carrying an empty vector or pGAL-HA-RHO1 were streaked out on YPGal at 308C or 378C.
tor2ts cells (SH137) carrying an empty vector are not viable at 378C. The tor2-37 allele was used in this experiment, because tor2-21 is
suppressed by galactose.
(C) Overexpression of RHO2 suppresses the actin organization defect in tor2ts cells. Logarithmic cultures of wild-type TOR2 (JK9-3da) (A and
D) and tor2ts (SH121) cells carrying an empty vector (B and E) or pRHO2 (C and F) were grown at 308C, shifted to 378C for 8 hr, fixed, stained
with TRITC-phalloidin, and observed by fluorescence (A–C) and Nomarski (D–F) microscopy. tor2ts cells carrying an empty vector have a
random actin distribution.
3A). We also assessed if overexpressionof constitutively (pCDC42*)or RHO3 (pRHO3*)did not suppress the lethal-
ity caused by loss of TOR2 (Figure 3A). We were unableactivated alleles of the small GTPases or overexpression
from a stronger promotor could restore growth in a tor2ts to examine suppression by an activated RHO1 allele
because such an allele is extremely toxic. However,mutant. Overexpression of activated alleles of CDC42
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galactose-induced overexpression of RHO1 under con- the empty vector suppressed the growth defect of a
rom2 mutant (data not shown). This finding, combinedtrol of the GAL1 promotor (pGAL-HA-RHO1) weakly sup-
pressed the lethality of a tor2ts mutation at 378C (Figure with the above observations that high copy number
ROM2, RHO1, or RHO2 can suppress a tor2 mutation,3B). Thus, specific overexpression of RHO1 or RHO2
suppressed the growth defect of a tor2 mutant. This is suggests that ROM2 is downstream of TOR2.
in agreement with our finding that BEM2, a GAP for
RHO1 and RHO2, may be involved in TOR2 function,
SAC7 and ROM2 Null Mutations Suppresswhereas BEM3 and RGA1, GAPs for CDC42, are not
Each Otherinvolved in TOR2 function.
Our findings that deletion of SAC7 and overexpressionThe high copy number plasmidpRHO2 was also trans-
of ROM2 suppress a tor2 mutation suggest that the GAPformed into tor1 tor2ts strain SH221. Overexpression of
homolog SAC7 and the GEF ROM2 have counteractingRHO2 was not able to suppress the growth defect of a
roles in mediating TOR2 function. To gain further evi-tor1 tor2ts mutant at nonpermissive temperature. There-
dence that SAC7 and ROM2 counteract each other, wefore, like disruption of SAC7, overexpression of RHO2
examined whether SAC7 and ROM2 null mutations sup-suppressed loss of the TOR2-unique function but not
pressed each other. First, the rom2, sac7, and rom2loss of the TOR1-shared function.
sac7 segregants from seven tetrads obtained by cross-To confirm that RHO2 overexpression suppressed the
ing rom2 strain AS138-1c to sac7 strain MB75-1c wereloss of an actin-related TOR2-unique function, we exam-
streaked out on rich medium (YPD) at 308C. Whereasined the actin cytoskeleton in a tor2 mutant overex-
rom2 cells exhibited a severe growth defect at this tem-pressing RHO2. Wild-type strain JK9-3da and tor2ts
perature, rom2 sac7 cells grew normally like sac7 cellsstrain SH121 transformed with pRHO2 and an empty
(data not shown). Second, rom2, sac7, and rom2 sac7vector were grown at permissive temperature (308C),
strains (AS138-1c, MB75-1c, and AS139-3d, respec-shifted to nonpermissive temperature (378C) for 8 hr,
tively) were streaked out on rich medium (YPD) at 158C.fixed, and stained with TRITC-phalloidin to visualize the
Whereas sac7 cells were severely impaired for growthactin cytoskeleton. In comparison to tor2ts cells carrying
at this temperature, sac7 rom2 cells exhibited betteran empty vector, which exhibited a random distribution
growth and resembled rom2 cells (data not shown).of actin in all phases of the cell cycle, tor2ts cells trans-
Thus, ROM2 and SAC7 indeed appear to antagonizeformed with pRHO2 showed less severe defects in the
each other, presumably by acting on the same Rho-likeorganization of the actin cytoskeleton (Figure 3C). Taken
GTPase(s).together, the above findings suggest that RHO1 and
RHO2, like SAC7, are involved in the actin-related TOR2
function and are downstream of TOR2 in a signaling
SAC7 Is a GAP for RHO1pathway.
The genetic and structural analyses of SAC7 described
above suggest that SAC7 is a GAP for RHO1 and/or
RHO2. We investigated this possibility first by using theOverexpression of the GDP/GTP Exchange
Factor ROM2 Suppresses the Growth yeast two-hybrid system to detect an interaction be-
tween SAC7 and one of these RHOs. A DNA fragmentDefect of a tor2 Mutant
Since overexpression of RHO1 or RHO2 restored growth encoding the full-length SAC7 protein was fused to lexA,
and the resulting plasmid (pEG202::SAC7) was trans-in a tor2ts mutant, we asked if overexpression of ROM2,
encoding the GDP/GTP exchange factor (GEF) for RHO1 formed into yeast strains that contained CDC42, RHO1,
or RHO2 fused to the transcriptional activating domainand RHO2, could also suppress a tor2ts mutation. The
tor2ts strain SH121 was transformed with the high copy of GAL4 (Stevenson et al., 1995). To facilitate the trans-
port of these fusion proteins to the nucleus, all GTPasesnumber plasmid pROM2, and transformants were moni-
tored for growth at 378C. As shown in Figure 6B, overex- carried a C→S substitution at the C terminus, which
removes the CAAX-box and prevents prenylation. It haspression of ROM2 restored growth of a tor2ts mutant at
nonpermissive temperature. Overexpression of ROM2 been shown previously that RGA1 interacts with CDC42
in the two-hybrid system and that this interaction iswas not able to suppress the growth defect of a tor1
tor2ts mutant (data not shown). specific for a CDC42 containing a G12V or a Q61L sub-
stitution, which traps the CDC42 protein in the GTP-We also examined if overexpression of TOR2 could
restore growth in a rom2 mutant. ROM2 was disrupted bound form (Stevenson et al., 1995; Figure 4A). Thus,
we also tested the interaction of SAC7 with CDC42Q61Lin our strain background (JK9-3da/a) to generate strain
AS138-1c. The rom2 strain AS138-1c had a growth de- and with the corresponding mutant RHO1 and RHO2
(RHO1Q68H and RHO2Q65H) proteins. Figure 4A shows thatfect at low temperatures (158C, 248C, and 308C). How-
ever, in contrast to what has been reported previously SAC7 strongly interacts with the GTP-bound activated
RHO1Q68H, but not with the unactivated form of RHO1.for a rom2 disruption in another strain background
(Ozaki et al., 1996), our rom2 strain grew on solid medium No interaction was detected between SAC7 and acti-
vated or unactivated CDC42 or RHO2. The finding thatat 378C almost like wild-type. AS138-1c cells (rom2)
were transformed with the high copy number plasmid the putative GAP SAC7 interacts only with an activated
form of RHO1 suggests that the interaction isphysiologi-pTOR2, a plasmid bearing ROM2, or an empty vector,
and streaked out on rich medium (YPD) at 308C. The cally relevant.
The above data suggest that SAC7 is a GAP for RHO1.ROM2 plasmid complemented the rom2 mutation. How-
ever, neither the high copy number TOR2 plasmid nor To investigate this further, we performed GAP assays
Cell
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this,we looked atwhether the GDP/GTP exchange activ-
ity of ROM2 toward RHO1 is decreased in a tor2 mutant
strain compared to a TOR2 wild-type strain. GDP/
[35S]GTPgS exchange activity toward RHO1 was mea-
sured in crude protein extracts prepared from TOR2
wild-type and tor2, rom2, and tor2 rom2 mutant strains
(JK9-3da, SH121, AS138-1c, and AS146-7c, respec-
tively) (see Experimental Procedures). As shown in Fig-
ure 5A, exchange activity on RHO1 was decreased to
approximately 32% in extracts from a tor2 mutant strain
Figure 4. SAC7 Is a GAP for RHO1.
compared to extracts from a wild-type strain. With ex-
(A) SAC7 interacts with activated RHO1 in the two-hybrid system.
tracts from the rom2 mutant, exchange activity was re-Yeast strain EGY48 transformed with either pEG202 (2), pEG-
duced to about 49%. In a tor2 rom2 double mutant202::SAC7 (SAC7), or pEG202::RGA1 (RGA1) and pJG4-5 (2), pJG4-
extract, exchange activity on RHO1 was reduced to ap-5::CDC42C188S (CDC42), pJG4-5::CDC42Q61L,C188S (CDC42Q61L), pJG4-
5::RHO1C206S (RHO1), pJG4-5::RHO1Q68H,C206S (RHO1Q68H), pJG4-5:: proximately 21%, indicating that the decrease in GEF
RHO2C188S,C189S (RHO2), or pJG4-5::RHO2Q65H,C188S,C189S (RHO2Q65H) and activity seen with the tor2 strain was caused mainly by
streaked out on SGal/Raffinose-URA-TRP-HIS/XGal plates at 308C. a loss of ROM2 GEF activity. The GEF activity remaining
Blue color (seen here as dark color) indicates a specific interaction in the mutant extracts could be due, at least in part, to
in the two-hybrid system.
ROM1. Thus, TOR2 controls ROM2 activity, suggesting(B) SAC7 has GAP activity toward RHO1. Epitope-tagged RHO1
that TOR2 regulates RHO1 and RHO2 through ROM2.(1) was immunoprecipitated and allowed to bind to [a-32P]GTP.
Immunoprecipitated SAC7 (1) or a mock immunoprecipitate (2) To determine whether the decrease in ROM2 activity
was added, the mixture was briefly incubated, and the guanine in a tor2 mutant was caused by a decrease in the amount
nucleotides were extracted from RHO1 and separated chromato- of ROM2 protein, a Western analysis was performed on
graphically. protein extracts from wild-type and tor2 mutant strains
transformed with the pHA-ROM2 plasmid encoding a
functional, epitope-tagged ROM2. As shown in Figure
with SAC7 and RHO1 or RHO2 (see Experimental Proce-
5B, HA-ROM2 was equally expressed in wild-type and
dures). Epitope-tagged RHO1 and RHO2 were immu-
tor2 mutant strains. Thus, the control of ROM2 by TOR2
noprecipitated and allowed to bind to [a-32P]GTP. Im-
was not at the level of ROM2 synthesis or stability.
munoprecipitated epitope-tagged SAC7 or a mock
immunoprecipitate were then added to the [a-32P]GTP-
bound RHO1 or RHO2. After a brief incubation, the gua- The PH Domain of ROM2 Is Required
for Suppression of a tor2 Mutationnine nucleotides were extracted and separated chro-
matographically. As shown in Figure 4B, addition of Like most of the GEFs for members of the Ras superfam-
ily, ROM2 possesses a PH domain C-terminally adjacentSAC7 enhanced the GTPase activity of RHO1 2.7-fold
from a basal level already high in the absence of SAC7. to its GEF domain (Ozaki et al., 1996). PH domains have
been shown to bind to phosphatidylinositol derivativesNo GAP activity of SAC7 toward RHO2 could be de-
tected (data not shown). Thus, SAC7 is a GAP for RHO1. and have been implicated in the activation of signaling
molecules (for reviews, see Lemmon et al., 1996; Shaw,
1996). We asked if the PH domain of ROM2 was neces-TOR2 Is Required for Activation of ROM2
Our results so far have suggested that SAC7, RHO1, sary for suppression of a tor2 mutation by high copy
ROM2. A ROM2 allele containing a PH domain deletion,RHO2, and ROM2 are a GTPase switch activated by
TOR2. One possibility for how TOR2 might activate this rom2DPH, was constructed (see Experimental Proce-
dures) (Figure 6A). The deletion did not affect the ROM2GTPase switch is that TOR2 activates ROM2. To test
Figure 5. TOR2 Is Required for ROM2 GEF
Activity
(A) GEF activity toward RHO1 is decreased
in a tor2 mutant strain. GDP/[35S]GTPgS ex-
change activity toward immunoprecipitated
RHO1 in crude protein extracts from TOR2
ROM2 (JK9-3da), tor2 ROM2 (SH121), TOR2
rom2 (AS138-1c), and tor2 rom2 (AS146-7c)
was measured. All strains were grown at 308C
and shifted to 378C for 8 hr before preparation
of extracts.
(B) ROM2 is equally expressed in wild-type
and tor2 mutant strains at 378C. Western
analysis was performed on protein extracts
from wild-type TOR2 (JK9-3da) and tor2
(SH121) mutant strains carryinga plasmid en-
coding HA-tagged ROM2. Equal amounts of
total protein were loaded in each lane.
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Figure 7. Model of TOR2 Signaling to the Actin Cytoskeleton
through a Rho-Type GTPase Switch Composed of RHO1, RHO2,
ROM2, and SAC7
See Discussion for further details.
sis of ROM2, suggesting that TOR2 might activate ROM2
via the ROM2 PH domain.
Discussion
We have shown previously that TOR2 is required for the
cell cycle–dependent organization of the actin cytoskel-
Figure 6. The PH Domain of ROM2 Is Required for Suppression of eton (Schmidt et al., 1996). Here, we describe several
a tor2 Mutation findings concerning the mechanismby which TOR2 con-
(A) Schematic representation of wild-type ROM2 and mutant trols the actin cytoskeleton. First, overexpression of
ROM2DPH lacking amino acids 908–1083. ROM2 is 1356 amino acids;
RHO1 or RHO2, encoding two Rho-like GTPases, orthe GEF and PH domains are amino acids 660–856 and 875–1000,
ROM2, encoding the guanine nucleotide exchange fac-respectively.
tor for RHO1 and RHO2, suppresses the growth defect(B) Wild-type TOR2 (JK9-3da) cells, tor2ts (SH121) cells carrying an
empty vector or pROM2, or pROM2DPH were streaked out on YPD of a tor2 mutant. RHO2 overexpression also suppresses
and incubated at 308C or 378C. tor2ts cells (SH121) carrying an empty the actin organization defect of a tor2 mutant. Second,
vector are not viable at 378C. deletion of SAC7, encoding a novel GTPase-activating
(C) ROM2DPH is stably expressed in tor2ts cells at 378C. Western
protein for RHO1, suppresses tor2 and rom2 null muta-analysis was performed on protein extracts from tor2ts strain SH121
tions. Importantly, SAC7 was originally identified as atransformed with either pHA-ROM2 or pHA-ROM2DPH, grown at 308C
second site suppressor of actin mutations that alter theand shifted to 378C for 8 hr. HA-ROM2DPH is approximately 20 kDa
smaller than HA-ROM2. Equal amounts of total protein were loaded polarized distribution of the actin cytoskeleton (Dunn
in each lane. and Shortle, 1990). Third, ROM2 GEF activity on RHO1
is reduced in a tor2 mutant. Fourth, the PH domain of
ROM2 is required for ROM2-mediated suppression of
tor2. These findings suggest that TOR2 signals to theGEF domain, and the deleted residues were shown pre-
viously not to be required for at least basal level ROM2 actin cytoskeleton by regulating a GTPase switch com-
posed of RHO1, RHO2, ROM2, and SAC7 (Figure 7).GEF activity (Ozaki et al., 1996). The tor2ts strain SH121
was transformed with pROM2 and pROM2DPH (high copy Because any condition known or predicted to enhance
the amount of activated GTPase (deletion of SAC7 ornumber plasmids containing ROM2 and rom2DPH, re-
spectively) and monitored for growth on rich medium at overexpression of RHO1, RHO2, or ROM2) suppresses a
tor2 mutation, TOR2 presumably activates this GTPase308C and 378C (Figure 6B). Whereas overexpression of
wild-type ROM2 restored growth at the nonpermissive switch. Furthermore, our finding that ROM2 GEF activity
is reduced in a tor2 mutant suggests that the PI kinasetemperature, overexpression of rom2DPH did not sup-
press the growth defect of the tor2ts mutant. Western homolog TOR2 activates RHO1 and RHO2 by activating
their exchange factor ROM2, possibly via the ROM2 PHblot analysis of whole cell extracts showed that the
epitope-tagged ROM2DPH protein (derived from func- domain. SAC7 and perhaps BEM2 down-regulate RHO1
and RHO2. It remains to be determined if TOR2 alsotional, epitope-tagged ROM2) was stably expressed in
the tor2 mutant (Figure 6C). Thus, the PH domain of controls cell wall synthesis via at least RHO1.
How does TOR2 activate ROM2? Our results suggestROM2 was required to suppress the lethality of a tor2ts
mutation but was not required for the stability or synthe- that this activation requires the TOR2 kinase domain
Cell
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Table 1. Yeast Strains Used in This Study
Strain Genotype
JK9-3da MATa leu2-3,112 ura3-52 trp1 his4 rme1 HMLa
JK9-3da MATa leu2-3,112 ura3-52 trp1 his4 rme1 HMLa
JK9-3da/a MATa/MATa leu2-3,112/leu2-3,112 ura3-52/ura3-52 trp1/trp1 his4/his4 rme1/rme1 HMLa/HMLa
SH121 JK9-3da ade2 tor2::ADE2-3/YCplac111::tor2-21ts
SH221 JK9-3da ade2 his3 HIS4 tor1::HIS3 tor2::ADE2-3/YCplac111::tor2-21ts
MB75-1c JK9-3da sac7::kanMX
AS100-6a JK9-3da sac7::kanMX ade2
AS100-3c JK9-3da ade2 tor2::ADE2-3/YCplac111::tor2-21ts
AS103 JK9-3da/a ade2/ade2 sac7::kanMX/SAC7 tor2::ADE2-3/TOR2/YCplac111::tor2-21ts
AS103-2a JK9-3da ade2 sac7::kanMX tor2::ADE2-3/YCplac111::tor2-21ts
AS109-19c JK9-3da sac7::kanMX ade2 his3 TRP1 HIS4
AS114 JK9-3da/a ade2/ade2 his3/his3 HIS4/HIS4 trp1/TRP1 sac7::kanMX/SAC7 tor1::HIS3/TOR1 tor2::ADE2-3/TOR2/
YCplac111:tor2-21ts
AS114-4c JK9-3da ade2 his3 HIS4 sac7::kanMX tor1::HIS3 tor2::ADE2-3/YCplac111::tor2-21ts
AS117-3c JK9-3da bem2::URA3
AS116-1d JK9-3da bem3::LEU2
AS149-1c JK9-3da rga1::URA3 ade2
AS115-3a JK9-3da bag7::HIS3 his3 HIS4
AS124 JK9-3da/a ade2/ade2 bem2::URA3/BEM2 tor2::ADE2-3/TOR2/YCplac111::tor2-21ts
AS131 JK9-3da/a ade2/ade2 bem3::LEU2/BEM3 tor2::ADE2-3/TOR2/YCplac33::tor2-21ts
AS130 JK9-3da/a ade2/ADE2 his3/his3 HIS4/HIS4 bag7::HIS3/BAG7tor2::ADE2-3/TOR2/YCplac111::tor2-21ts
AS149 JK9-3da/a ade2/ade2 rga1::URA3/RGA1 tor2::ADE2-3/TOR2/YCplac111::tor2-21ts
AS147-1a JK9-3da ade2 sac7::kanMX tor2::ADE2-3/YCplac33::tor2-21ts
AS129-1d JK9-3da ade2 tor2::ADE2-3/YCplac33::tor2-21ts
SH137 JK9-3da ade2 tor2::ADE2-3/YCplac111::tor2-37ts
AS138-1c JK9-3da rom2::URA3
AS139-3d JK9-3da rom2::URA3 sac7::kanMX
AS146-7c JK9-3da ade2 rom2::URA3 tor2::ADE2-3/YCplac111::tor2-21ts
(Schmidt et al., 1996) and the ROM2 PH domain and is and simple possibility is that TOR2, as a PI kinase, pro-
duces a phosphorylated phosphoinositide that bindsnot at the level of ROM2 synthesis or stability. Further-
more, using the two-hybrid system, we did not detect the ROM2 PH domain and thereby activates ROM2. This
signaling from TOR2 to ROM2 through a phosphorylateda direct interaction between TOR2 and ROM2 (A. S.,
T. B., and M. N. H., unpublished data). Thus, an attractive phosphoinositide intermediatecould bedirect, as TOR2,
Table 2. Plasmids Used in This Study
Plasmid Characteristics and Source
pSAC7 5 pMB7, SAC7 in YEplac195 (2m, URA3). Made by subcloning a 3.5 kb HindIII–EcoRI fragment from YEp13::SAC7
into YEplac195.
pRGA1 5 pRGA1.3, RGA1 in YEp24 (2m, URA3) (Stevenson et al., 1995)
pBEM2 5 pPB415, BEM2 in pTSV30A (2m, LEU2, ADE3) (A. Bender, Indiana University, Bloomington)
pBEM3 5 pPB547, BEM3 in pSC113 (2m, LEU2) (A. Bender, Indiana University, Bloomington)
pBAG7 5 pAS33, BAG7 in pSEY18 (2m, URA3). Made by subcloning a 3.4 kb BglII fragment from cosmid pEOA986 (V. Benes,
EMBL, Heidelberg, Germany) into the BamHI site of pSEY18.
pCDC42 5 pPB102, CDC42 in YEp24 (2m, URA3) (Bender and Pringle, 1989)
pCDC42* 5 YCp(CDC42SCval12) (2m, LEU2) (Ziman et al., 1991)
pRHO1 5 RHO1 in YEp24 (2m, URA3) (Y. Takai, Osaka University Medical School, Japan)
pRHO2 5 pC-186, RHO2 (2m, URA3) (Madaule et al., 1987)
pRHO3 5 pYO324-RHO3 (2m, TRP1) (Y. Matsui, University of Tokyo, Japan)
pRHO3* 5 pRS314-RHO3val25 (CEN, TRP1) (Imai et al., 1996)
pRHO4 5 pOPR4, RHO4 (2m, TRP1) (Matsui et al., 1992)
pGAL-HA-RHO1 5 pTB230, expresses N-terminally HA-tagged RHO1 under the control of the GAL1 promotor in pAS25 (pSEYC68galp,
CEN, URA3, GAL1 promotor, HA-tag)
pROM2 5 pAS30, ROM2 in YEplac195 (2m, URA3). Made by subcloning a 6.3 kb BglII–HindIII fragment containing the entire
ROM2 gene from cosmid YSCL8039 (from ATCC, Rockville, Maryland)
pTOR2 5 pJK6, TOR2 in YEplac181 (2m, LEU2)
pGAL-HA-SAC7 5 pAS31, expresses N-terminally HA-tagged SAC7 under the control of the GAL1 promotor in pAS24 (YCplac111galp,
CEN, LEU2, GAL1 promotor, HA-tag)
pGAL-HA-RHO2 5 pAS35, expresses N-terminally HA-tagged RHO2 under the control of the GAL1 promotor in pAS25 (CEN, URA3,
GAL1 promotor, HA-tag)
pHA-ROM2 5 pAS32, encodes N-terminally HA-tagged ROM2 in YEplac195 (2m, URA3)
pROM2DPH 5 pAS36, contains rom2DPH in YEplac195 (2m, URA3), made by an in-frame deletion of a 528 bp XbaI–SpeI fragment
(amino acids 908–1083)
pHA-ROM2DPH 5 pAS37, same as pROM2DPH but encodes N-terminally HA-tagged ROM2DPH
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as previously published for other strain backgrounds (Zheng et al.,RHO1, RHO2, and presumably activeROM2 are all local-
1994; Stevenson et al., 1995). BAG7 was disrupted by replacingized at the plasma membrane (J. Kunz, U. Schneider,
the entire BAG7 open reading frame with a PCR-generated DNAI. Stevenson, and M. N. H, unpublished data; A. S. and
fragment containing the HIS3 module (A. Wach, and P. Philippsen,
M. N. H., unpublished data; Yamochi et al., 1994). An- Biozentrum, Basel, Switzerland) flanked by 45 bp homologous to
other possibility is that the activation is by phosphoryla- the region either upstream of the start codon or downstream of the
stop codon of BAG7. A bag7::HIS3 strain (AS115-3a) grew normallytion of ROM2, as has been suggested recently for the
at all temperatures. To disrupt ROM2, the internal 1.9 kb XbaI frag-activation of the PH domain–containing protein kinase
ment of the ROM2 gene was replaced with a 1 kb XbaI fragmentAkt/PKB (Kohn et al., 1996). TOR2 or another protein
containing the URA3 gene. A 3.2 kb EcoRI fragment containingcould be the activating protein kinase. TOR2 has not
rom2::URA3 was transformed into yeast. All of the above disruptions
yet been demonstrated to be either a lipid or a protein were verified by Southern analysis.
kinase. Although we find the above models appealing,
our data do not exclude other, more indirect mecha- Two-Hybrid Assays
The Interaction Trap two-hybrid system was used (Gyuris et al.,nisms of ROM2 activation by TOR2.
1993). Plasmids pEG202, pJG4-5, and yeast strain EGY48 were ob-What is upstream of TOR2 in controlling RHO1 and
tained from R. Brent (MGH, Boston). Plasmids pEG202::RGA1,RHO2? TOR1 and TOR2 activate translation initiation in
pJG4-5::CDC42C188S, pJG4-5::CDC42Q61L,C188S, pEG202::RHO1C206S,response to nutrients (Barbet et al., 1996; Di Como and and pEG202::RHO2C188S,C189S wereobtained from C. De Virgilio (Botan-
Arndt, 1996). TOR2 might also control RHO1 and RHO2 isches Institut, University of Basel, Basel, Switzerland). pJG4-5::
and eventually cell polarity, in response to nutrients. RHO2C188S,C189S was constructed by subcloning an 0.8 kb EcoRI–XhoI
fragment from pEG202::RHO2C188S,C189S into pJG4-5. To constructInterestingly, under conditions of nitrogen starvation, S.
pJG4-5::RHO2Q65H,C188S,C189S, PCR-based mutagenesis was performedcerevisiae undergoes filamentous growth as a foraging
with the mutagenic primers 59-GATACAGCGGGACATGAGGAATATresponse (Kron and Gow, 1995). Filamentous growth is
GAACG and 59-CGTTCATATTCCTCATGTCCCGCTGTATC and thecaused by a change in the normal pattern of polarized
flanking primers 59-AGCGACCTCATGCTATAC and59-CGTCAGCAG
cell growth and is presumably elicited by an underlying AGCTTCAC and pEG202::RHO2C188S,C189S as template. A 0.8 kb
change in the actin cytoskeleton (Mo¨sch et al., 1996). EcoRI–XhoI fragment was excised and subcloned into pJG4-5.
pJG4-5::RHO1C206S was constructed by subcloning a 0.8 kb EcoRI–The pathway we propose above for yeast cells may be
XhoI fragment from pEG202::RHO1C206S into pJG4-5. To constructconserved in mammalian cells. Mammalian PI 3-kinase
pJG4-5::RHO1Q68H,C206S, the mutant RHO1Q68H allele (plasmid p68-induces actin reorganization by Rac- and Rho-depen-
LEUe (Madaule et al., 1987)) was amplified by PCR with primersdent pathways (Reif et al., 1996) and is also possibly
(59-CGCTCGAGATGTCACAACAAGTTGGTA and 59-GACACTCGAG
upstream of mTOR (FRAP/RAFT) (Downward, 1995). CTATAACAAGACAGACTTCTTCTTC) that introduced XhoI cloning
Furthermore, mammalian RhoA can substitute for RHO1 sites at the N terminus and C terminus of RHO1 as well as a single
nucleotide change converting codon 206 from TGT (C) to TCT (S).in yeast cells (Qadota et al., 1994). Thus, TOR may be
The PCR product was digested with XhoI and cloned into pJG4-5.upstream of Rho-type GTPases in mediating actin
pEG202::SAC7 was constructed by subcloning a 2.5 kb SalI–XhoIchanges in mammalian cells. However, it remains to be
fragment containingthe entire SAC7 open reading frame from pAS31demonstrated that mTOR has a role in actin organization
into pEG202. To assess b-galactosidase activities, strain EGY48
and that it is indeed upstream of a Rho-type GTPase. containing the lexAop–lacZ reporter plasmid pSH18-34 (Gyuris et
al., 1993) was cotransformed with either pEG202 or with a pEG202-
Experimental Procedures derived plasmid expressing a LexA BD fusion protein and with
pJG4-5 or a pJG4-5-derived plasmid expressing an AD fusion pro-
Strains, Plasmids, and Media tein and four independent transformants of each combination were
S. cerevisiae strains used in this work are listed in Table 1. All strains streaked out on SGal/Raffinose-URA-TRP-HIS/XGal plates.
were isogenic JK9-3da derivates. Plasmids used in this study are
listed in Table 2. The composition of rich medium (YPD, YPGal) SAC7 GAP Activity Assay
and synthetic minimal medium (SD, SGal) complemented with the The GAP activity of HA-SAC7 was assayed by guanine nucleotide
appropriate nutrients for plasmid maintainance was as described analysis by thin layer chromatography as described (Tanaka et al.,
(Guthrie and Fink, 1991). 1991; Park et al., 1993), with slight modifications. All procedures
were at 48C unless stated otherwise. SAC7 was expressed in yeast
Fluorescence Microscopy from the GAL1 promotor as a fusion protein with a HA epitope at
Cells were grown to early logarithmic phase, fixed in formaldehyde, the N terminus (pAS31). The HA-SAC7 construct encoding epitope-
and stained with TRITC-phalloidin (Sigma) to visualize actin as de- tagged SAC7 complemented a sac7 deletion strain (A. S., unpub-
scribed (Benedetti et al., 1994). lished data). RHO1 was expressed in yeast from the GAL1 promotor
as a fusion protein with a HA epitope at the N terminus (pTB230).
To prepare whole cell extracts, yeast cells were resuspended inGene Disruptions
To disrupt SAC7, we replaced the entire open reading frame of extraction buffer I (50 mM Tris-HCl (pH 7.5) 50 mM NaCl, 0.1 mM
EDTA, 0.1% NP-40, 10% glycerol, and various protease inhibitors),SAC7 with a PCR-generated DNA fragment containing the kanMX2
module (Wach et al., 1994) flanked by 59 bp and 57 bp homologous lysed with glassbeads in a bead-beater, and centrifuged at 500 3
g for 5 min to remove cell debris. HA-tagged SAC7 and HA-taggedto the region either directly upstream of the start codon or down-
stream of the stop codon of SAC7. BEM2 was disrupted by transfor- RHO1 were immunoprecipitated from approximately 0.2 mg whole
cell extract with anti-HA antibody (BabCO, Berkeley) and goat anti-mation of a 4 kb SspI–SalI fragment containing bem2::URA3 (Pe-
terson et al., 1994). The bem2::URA3 disruption in our strain mouse IgG-coupled protein A–Sepharose beads. As the control
(2 SAC7, Figure 4B), a mock immunoprecipitation was performedbackground (AS117-3c) conferred slow growth at all temperatures,
but the growth defect was less severe at high temperature (378C). with the same anti-HA antibody but with an extract of cells lacking
HA-tagged SAC7. After washing 5 times with extraction buffer IBEM3 was disrupted by transformation of a 3 kb XhoI–BamHI frag-
ment containing bem3::LEU2 (Zheng et al., 1994). RGA1 was dis- containing 500 mM NaCl and 0.5% Triton X-100 and once with
extraction buffer I, the immune complex containing RHO1 was al-rupted by transformation of a 5.8 kb HindIII fragment containing
rga1::URA3 (Stevenson et al., 1995). The bem3::LEU2 and lowed to bind to 1 mCi [a-32P]GTP (Amersham) for 15 min at 258C.
The reaction was stopped on ice, mixed with the immune complexrga1::URA3 disruptions did not confer any growth defect in our
strain background (strains AS116-1d and AS149-1c, respectively), containing HA-tagged SAC7 (1 SAC7) or the control (2 SAC7) in
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extraction buffer I containing 2 mM DTT, 2 mM MgCl2, and incubated Pringle, J.R. (1990). CDC42 and CDC43, two additional genes in-
volved in budding and the establishment of cell polarity in the yeastfor 5 min at 258C. The beads were washed 3 times with extraction
buffer I, and the nucleotides were eluted from RHO1 by incubating Saccharomyces cerevisiae. J. Cell Biol. 111, 131–142.
with 15 ml of nucleotide elution buffer (1% SDS, 20 mM EDTA) for Barbet, N.C., Schneider, U., Helliwell, S.B., Stansfield, I., Tuite, M.F.,
5 min at 658C. The nucleotides were loaded onto a PEI cellulose and Hall, M.N. (1996). TOR controls translation initiation and early
plate (Merck) and chromatographed in 1 M LiCl. After autoradiogra- G1 progression in yeast. Mol. Biol. Cell 7, 25–42.
phy, the amount of each nucleotide was quantifiedusing a Molecular
Barfod, E.T., Zheng, Y., Kuang, W.-J., Hart, M.J., Evans, T., Cerione,Dynamics Phosphoimager. SAC7 GAP activity on functional, HA-
R.A., and Ashkenazi, A. (1993). Cloning and expression of a humantagged RHO2 was also assayed, as described above for RHO1.
CDC42 GTPase-activating protein reveals a functional SH3-bindingIdentical results were obtained in two independent assays, for both
domain. J. Biol. Chem. 268, 26059–26062.RHO1 and RHO2.
Benedetti, H., Raths, S., Crausaz, F., and Riezman, H. (1994). The
END3 gene encodes a protein that is required for the internalizationGEF Activity Assay
step of endocytosis and for actin cytoskeleton organization in yeast.The GEF activity of various strains toward RHO1 was assayed by
Mol. Biol. Cell 5, 1023–1037.measuring the binding of [35S]GTPgS to RHO1 as described, with
slight modifications (Yamamoto et al., 1990). All procedures were Beretta, L., Gingras, A.-C., Svitkin, Y.V., Hall, M.N., and Sonenberg,
at 48C, unless stated otherwise. Whole cell extracts from various N. (1996). Rapamycin blocks the phosphorylation of 4E-BP1 and
yeast strains were prepared by resuspending cells in extraction inhibits cap-dependent initiation of translation. EMBO J. 15,
buffer II (20 mM Tris-HCl (pH 7.5) 10 mM MgCl2, 2.5 mM EDTA, 1 mM 658–664.
DTT, and various protease inhibitors), lysing with glass beads in a Cafferkey, R., Young, T.R., McLaughlin, M.M., Bergsma, D.J., Koltin,
bead-beater, and removing cell debris by centrifugation at 500 3 g Y., Sathe, G.M., Faucette, L., Eng, W.K., Johnson, R.K., and Livi,
for 10 min. HA-tagged RHO1 was immunoprecipitated from whole- G.P. (1993). Dominant missense mutations in a novel yeast protein
cell extracts as described above. The immune complex containing related to mammalian phosphatidylinositol 3-kinase and VPS34 ab-
RHO1 was resuspended in extraction buffer II and incubated with rogate rapamycin toxicity. Mol. Cell. Biol. 13, 6012–6023.
1 mM [35S]GTPgS (Amersham) in the presence of 100 mg of whole
Chen, G.C., Zheng, L., and Chan, C.S.M. (1996). The LIM domain–cell extract and 1 mM DTT, 0.75 mM L-a dimyristoylphosphatidyl-
containing Dbm1 GTPase-activating protein is required for normalcholine for 5 min at 258C. The reaction was stopped by adding 1
cellular morphogenesis in Saccharomyces cerevisiae. Mol. Cell.ml of ice-cold stop buffer (20 mM Tris-HCl, (pH 7.5), 25 mM MgCl2,
Biol. 16, 1376–1390.100 mM NaCl). The diluted mixture was filtered through nitrocellu-
Devereux, J., Haeberli, P., and Smithies, O. (1984). A comprehensivelose filters presoaked in stop buffer, and the filters were washed
set of sequence analysis programs for the VAX. Nucl. Acids Res.twice with stop buffer. The radioactivity trapped on the filters was
12, 387–395.quantified by scintillation counting. The GEF activity on RHO1 was
calculated by subtracting the background, i.e., the radioactivity Di Como, C.J. and Arndt, K.T. (1996). Nutrients, via the TOR proteins,
trapped on filters in the same experiment except that the immuno- stimulate the association of Tap42 with type 2A phosphatases.
precipitation was done from extracts of cells lacking HA-tagged Genes Dev. 10, 1904–1916.
RHO1. The GEF activity on RHO1 in the mutant extract was ex- Downward, J. (1995). A target for PI 3 kinase. Nature 376, 353–354.
pressed as percentage of the GEF activity on RHO1 in the wild-type
Drgonova, J., Drgon, T., Tanaka, K, Kollar, R., Chen, G.C. Ford, R.A.,extract.
Chan, C.S., Takai, Y., and Cabib, E. (1996). Rho1p, a yeast protein at
the interface between cell polarization and morphogenesis. ScienceMiscellaneous Methods
272, 277–279.Whole cell extracts for SDS–PAGE and Western Analysis were pre-
Drubin, D.G. (1991). Development of cell polarity in budding yeast.pared by resuspending cells in extraction buffer I, lysing them with
Cell 65, 1093–1096.glass beads in a bead-beater, and removing cell debris by centrifu-
gation at 500 3 g for 10 min. SDS–PAGE and Western analysis were Dunn, T.M., and Shortle, D. (1990). Null alleles of SAC7 suppress
done by standard methods. Yeast transformation was performed temperature-sensitive actin mutations in Saccharomyces cerevis-
by the lithium acetate procedure (Ito et al., 1983). Escherichia coli iae. Mol. Cell. Biol. 10, 2308–2314.
strain DH5a was used for propagation and isolation of plasmids as Errede, B., and Levin, D.E., (1993). A conserved kinase cascade for
described (Sambrook et al., 1989). Restriction enzyme digests and MAP kinase activation in yeast. Curr. Opin. Cell Biol. 2, 254–260.
ligations were done by standard methods. All enzymes and buffers
Guthrie, C., and Fink, G.R., eds. (1991). Methods in Enzymology:were obtained commercially (Boehringer Mannheim). The EMBL and
Guide to Yeast Genetics and Molecular Biology, Volume 194 (NewGenBank data bases were searched for SAC7 homologs using the
York: Academic Press).BLAST program (Devereux et al., 1984).
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